Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation on Mounjaro is common, particularly in the first few weeks of treatment or after a dose increase. Because tirzepatide slows the rate at which food moves through the gut, some people find their bowel habits change noticeably. It is a recognised side effect listed in the NHS patient information for tirzepatide, and for most people it is manageable with simple, practical steps. Mounjaro is a prescription-only medicine; a clinician assesses whether it is suitable for you and can advise on managing side effects throughout your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether constipation means the treatment is not working, or whether it is a reason to stop. Neither. Tirzepatide activates GIP and GLP-1 receptors that, among other effects, slow gastric emptying. Slower gut transit means stool spends longer in the colon, where water is reabsorbed, making it harder and drier. The effect is well-documented and tends to be most pronounced at the 2.5mg starting dose and at each subsequent increase, before settling as your system adjusts.
It helps to know this before you reach for any remedy, because the approach that works during a dose-increase window may be lighter touch than what someone needs if the constipation has persisted for several weeks. The mechanism behind why Mounjaro causes constipation is worth reading if you want the fuller picture before deciding what to do.
Dehydration makes everything worse. Because appetite often falls sharply on tirzepatide, many people also drink less without noticing. Replacing the lost meal-time fluids with plain water throughout the day is the single most immediate thing to address. Aim for pale yellow urine as a rough guide, rather than a fixed number of glasses.
Most people find constipation relief on Mounjaro comes from a small cluster of consistent changes rather than any single fix. Fluid intake is the first lever, as above. The second is dietary fibre, but the type matters: soluble fibre (oats, lentils, fruit, vegetables) bulks the stool gently and draws water in, which is what you want. Insoluble fibre alone can occasionally worsen bloating if gut transit is already slow, so variety is better than a large dose of wheat bran.
Gentle movement helps, too. A 20-minute walk after a meal is more useful than it sounds for stimulating gut motility. For a practical, step-by-step overview of what people have found useful, this page on relieving constipation on Mounjaro goes through each approach in order.
Over-the-counter osmotic laxatives (such as macrogol/polyethylene glycol, available from a pharmacist) are generally considered first-line for short-term constipation and are not known to interact with tirzepatide, but it is worth checking with your prescriber or pharmacist before adding any regular supplement or laxative to your routine. Stimulant laxatives taken frequently can, over time, make the bowel more sluggish, so they sit further down the list.
Some people find the constipation pattern shifts after the first month at a stable dose, and it is also a good moment to read about the Mounjaro blindness risk so you have a full picture of the side effects that warrant monitoring. Checking the broader Mounjaro side-effect picture can help you place this in context alongside the other GI effects that may occur.
Most constipation on Mounjaro is uncomfortable rather than dangerous. There are situations, though, where waiting it out is the wrong call.
Get same-day medical help if you develop severe abdominal pain, particularly pain that is persistent and spreads to your back, with or without vomiting. This pattern can indicate acute pancreatitis, a recognised but infrequent serious side effect of GLP-1 medicines. In January 2026, the MHRA issued a formal Drug Safety Update highlighting pancreatitis risk with this class of medicine; report any suspected serious reaction via Yellow Card.
Other signs that warrant prompt medical review include: no bowel movement for more than a week despite self-care measures; abdominal bloating that becomes increasingly distended and painful; blood in your stool; or signs of dehydration from severe vomiting or diarrhoea alongside constipation (which can happen when gut symptoms alternate). If you are unsure whether what you are experiencing is within the normal range, your prescriber is the right first call. Understanding the difference between expected and unexpected constipation on tirzepatide may help you assess your situation.
This is a prescription-only medicine, and ongoing clinical oversight matters. At nume, every repeat order is reviewed by a GPhC-registered prescriber before dispatch, not as a formality, but as a genuine opportunity to flag anything that has changed, including side effects like constipation that are persisting or worsening.
Constipation and other GI side effects are real, but they are also one of the most manageable parts of Mounjaro treatment for most people. They cluster around the early weeks and each dose step. By the time someone reaches a stable maintenance dose, GI symptoms have often reduced significantly. That pattern is consistent with what the clinical trial programme reported, and it is worth holding onto when the first few weeks feel uncomfortable.
If you are still weighing up whether Mounjaro is the right option for you, the Mounjaro treatment overview covers the licensed indications, the evidence base and what the process looks like at a private pharmacy. For a broader look at weight-loss treatment options, the weight-loss treatments page compares what is currently licensed in the UK.
Our prescribers talk through expected side effects (including constipation) as part of every consultation, and can advise on what to monitor and when to reach out. If you would like that conversation, start your free consultation and a prescriber will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.